[
  {
    "ts": "2026-02-17T14:00:00+00:00",
    "headline": "GE HealthCare builds on BARDA collaboration with approximately $35 million expansion to advance artificial intelligence-powered ultrasound for trauma care and emergency preparedness",
    "summary": "CHICAGO, February 17, 2026--GE HealthCare (Nasdaq: GEHC) today announced a new approximately $35 million expansion to a previous contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). The expansion is structured as a cost-share between BARDA and GE HealthCare, with BARDA providing the majority of funding. This jointly funded expanded",
    "url": "https://finance.yahoo.com/news/ge-healthcare-builds-barda-collaboration-140000255.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "159e4efe-e9a2-3e77-8dbe-0552aa59f1cd",
      "content": {
        "id": "159e4efe-e9a2-3e77-8dbe-0552aa59f1cd",
        "contentType": "STORY",
        "title": "GE HealthCare builds on BARDA collaboration with approximately $35 million expansion to advance artificial intelligence-powered ultrasound for trauma care and emergency preparedness",
        "description": "",
        "summary": "CHICAGO, February 17, 2026--GE HealthCare (Nasdaq: GEHC) today announced a new approximately $35 million expansion to a previous contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). The expansion is structured as a cost-share between BARDA and GE HealthCare, with BARDA providing the majority of funding. This jointly funded expanded",
        "pubDate": "2026-02-17T14:00:00Z",
        "displayTime": "2026-02-17T14:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/ge-healthcare-builds-barda-collaboration-140000255.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ge-healthcare-builds-barda-collaboration-140000255.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GEHC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-17T16:20:00+00:00",
    "headline": "Tempus AI & Median Partner to Add AI Lung Cancer Screening to Pixel",
    "summary": "TEM teams with Median to add FDA-cleared eyonis LCS to Pixel, boosting AI lung cancer screening and expanding its imaging portfolio.",
    "url": "https://finance.yahoo.com/news/tempus-ai-median-partner-add-162000559.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "64eb3bf0-3015-3edc-a8cd-7097b464156d",
      "content": {
        "id": "64eb3bf0-3015-3edc-a8cd-7097b464156d",
        "contentType": "STORY",
        "title": "Tempus AI & Median Partner to Add AI Lung Cancer Screening to Pixel",
        "description": "",
        "summary": "TEM teams with Median to add FDA-cleared eyonis LCS to Pixel, boosting AI lung cancer screening and expanding its imaging portfolio.",
        "pubDate": "2026-02-17T16:20:00Z",
        "displayTime": "2026-02-17T16:20:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/00e8f1a41a7bc7b2ecf8d421f3c6f574",
          "originalWidth": 620,
          "originalHeight": 343,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/N5xEJDQ9Yr4pXNEJ_c.8WA--~B/aD0zNDM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/00e8f1a41a7bc7b2ecf8d421f3c6f574.cf.webp",
              "width": 620,
              "height": 343,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/j8jgIs0er2qzWmssl7aBuQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/00e8f1a41a7bc7b2ecf8d421f3c6f574.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/tempus-ai-median-partner-add-162000559.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/tempus-ai-median-partner-add-162000559.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ALMDT.PA"
            },
            {
              "symbol": "ISRG"
            },
            {
              "symbol": "TEM"
            },
            {
              "symbol": "ATRC"
            },
            {
              "symbol": "GEHC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-17T16:12:00+00:00",
    "headline": "QDEL Expands Immunoassay Portfolio Via Lifotronic Supply Agreement",
    "summary": "QuidelOrtho inks Lifotronic supply deal, adding 70+ assays and new analyzer platforms to boost global immunoassay reach and recurring revenue potential.",
    "url": "https://finance.yahoo.com/news/qdel-expands-immunoassay-portfolio-via-161200671.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "07c36955-d481-34d0-9ed4-5e855499fa91",
      "content": {
        "id": "07c36955-d481-34d0-9ed4-5e855499fa91",
        "contentType": "STORY",
        "title": "QDEL Expands Immunoassay Portfolio Via Lifotronic Supply Agreement",
        "description": "",
        "summary": "QuidelOrtho inks Lifotronic supply deal, adding 70+ assays and new analyzer platforms to boost global immunoassay reach and recurring revenue potential.",
        "pubDate": "2026-02-17T16:12:00Z",
        "displayTime": "2026-02-17T16:12:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/955c0f2ed0992898cedf76a9efa5b1f2",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/54CAf0a.xcVnm138kMlg2g--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/955c0f2ed0992898cedf76a9efa5b1f2.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Qq8AX6cTgCCg_4Ye3FJ4Gw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/955c0f2ed0992898cedf76a9efa5b1f2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/qdel-expands-immunoassay-portfolio-via-161200671.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/qdel-expands-immunoassay-portfolio-via-161200671.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "QDEL"
            },
            {
              "symbol": "ISRG"
            },
            {
              "symbol": "GEHC"
            },
            {
              "symbol": "ATRC"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]